Skip to content
Home/ Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (2022)
Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (2022)
Save Ask us
Published
May 13, 2023
ISBN-13
9783030963781

Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies (2022)

No customer reviews yet ISBN 9783030963781

This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.

The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes bothsolid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies.

Product details

Pub dateMay 13, 2023
ISBN-103030963780
ISBN-139783030963781
LanguageEnglish
Last updated 2026-09-26 20:08
$114.64
In stock — ships in 24 hours with free tracking
Delivery by Monday, October 26, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Oncology - General
See all
Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
Stern, Theodore
$20.36
Cancer Pain Management
Fisch, Michael
$251.58
MD Anderson Manual of Psychosocial Oncology
Duffy, James D
$101.14
Gynecologic Oncology: Clinical Practice and Surgical Atlas
Karlan, Beth Y
$320.70
Harrison's Manual of Oncology
Chabner, Bruce a
$95.77
Advances in Cancer Research
Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
$103.10